Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.86M Buy
85,017
+1,405
+2% +$80.6K 0.45% 45
2026
Q2
$4.23M Buy
83,612
+78,146
+1,430% +$4.79M 0.41% 54
2026
Q1
$357K Sell
5,466
-13,426
-71% -$982K 0.03% 419
2025
Q4
$1.52M Buy
18,892
+4,600
+32% +$370K 0.21% 194
2025
Q3
$1.17M Buy
14,292
+4,232
+42% +$367K 0.18% 233
2025
Q2
$918K Buy
+10,060
New +$899K 0.14% 279
2024
Q2
– Sell
-8,676
Closed -$784K – 334
2024
Q1
$784K Sell
8,676
-4,158
-32% -$379K 0.7% 15
2023
Q4
$1.13M Sell
12,834
-4,063
-24% -$339K 0.32% 95
2023
Q3
$1.43M Buy
+16,897
New +$1.53M 0.42% 47
2022
Q2
– Sell
-6,333
Closed -$520K – 243
2022
Q1
$520K Sell
6,333
-526
-8% -$41.2K 0.27% 154
2021
Q4
$514K Buy
+6,859
New +$515K 0.4% 95

Other funds holding DOX

Oak Thistle's DOX Position: Q3 2026 in Review

Oak Thistle increased its Amdocs (DOX) stake by 1.7% in Q3 2026, buying an estimated $80.6K and bringing the position to 85,017 shares worth $4.86M. The position accounts for 0.45% of the portfolio, ranked #45.

Oak Thistle first reported a position in DOX in Q4 2021 and has held it in 11 quarters since. 359 funds tracked by Wall St. Rank hold DOX as of Q3 2026.

  • Oak Thistle held 85,017 shares of Amdocs worth $4.86M as of Q3 2026.
  • Oak Thistle bought 1,405 Amdocs shares in Q3 2026, an estimated $80.6K.
  • Amdocs made up 0.45% of Oak Thistle's portfolio in Q3 2026, its #45 holding.
  • Oak Thistle first reported a position in Amdocs in Q4 2021 and has held it in 11 quarters since.
  • 359 funds tracked by Wall St. Rank held Amdocs as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.